CNO Financial Group filings document the insurance holding company's operating results, governance and capital actions. Form 8-K reports furnish quarterly financial results, financial supplements and operating presentations covering life and health insurance, annuities, distribution activity, investment results and capital management.
Proxy and governance filings address annual meeting voting items, director elections, board committee matters, executive compensation and director compensation. Other material-event reports disclose dividend declarations, board appointments or retirements, Regulation FD presentations and securities identified in the company's capital structure.
CNO Financial Group, Inc. insider reports charitable stock donation
An officer of CNO Financial Group, Inc. (ticker CNO), identified as the President, Worksite Division, reported a charitable donation of company stock. On 11/25/2025, the insider disposed of 1,500 shares of CNO common stock in a transaction coded "G," which denotes a charitable gift, at a reported price of $0 per share. Following this transaction, the insider directly beneficially owns 40,355 shares of CNO common stock. The filing shows no derivative security transactions and indicates the report is filed by one reporting person.
CNO Financial Group has a planned insider sale of up to 3,000 shares of its common stock, with an aggregate market value of $123,000, as disclosed in a Form 144 notice. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 11/24/2025. These securities were acquired from the issuer on 01/02/2024 as 1,800 performance shares and 1,200 shares of restricted stock, both fully paid. Shares of CNO common stock outstanding were 95,353,512 as of the figure reported, which serves as a baseline ownership context.
CNO Financial Group, Inc. CEO and director Gary C. Bhojwani reported a sale of company stock. On 11/20/2025, he sold 31,430 shares of common stock at a weighted average price of $39.9727 per share in an open market transaction coded as a sale. After this transaction, he beneficially owns 227,356 shares directly and 635,471 shares indirectly through the Gary C. Bhojwani Revocable Trust. The filing notes that the shares were sold pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025, with sales executed at prices ranging from $39.49 to $40.465 per share.
CNO Financial Group, Inc. filed a Form 4 reporting a charitable stock donation by its Chief Financial Officer. On 11/20/2025, the CFO disposed of 3,740 shares of CNO common stock in a transaction coded "G," which the filing identifies as a charitable donation at a price of $0 per share. After this transaction, the reporting person directly beneficially owns 195,467.077 shares of CNO common stock. The filing is made by one reporting person and reflects a personal charitable transfer rather than an open-market sale.
A shareholder of CNO (symbol CNO) filed a Form 144 notice indicating an intention to sell 31,430 shares of CNO common stock through Morgan Stanley Smith Barney LLC on the NYSE. The filing lists an aggregate market value of 1,256,222.53 for the shares to be sold, compared with 95,353,512 shares of common stock outstanding. The shares come from restricted stock acquired on 03/25/2022 and performance shares acquired on 02/14/2023, both issued by the company and marked as not involving separate cash payment. The seller also represents that they are not aware of any undisclosed material adverse information about CNO’s operations.
CNO Financial Group reported an insider stock transaction by its General Counsel. On 11/17/2025, the officer made a charitable donation of 2,000 shares of CNO common stock, recorded with transaction code G and a reported price of $0. After this donation, the officer directly beneficially owns 275,916 shares of CNO common stock. The filing reflects a routine change in ownership rather than an open-market purchase or sale.
CNO Financial Group (CNO) disclosed an insider transaction by its Chief Investment Officer. On 11/10/2025, the executive exercised 71,400 employee stock options at an exercise price of $17.38 per share and then sold 48,665 shares at a $41.2414 weighted average price to cover the exercise price and required taxes. Following these transactions, the executive beneficially owned 671,542 shares directly. The options relate to grants that vested on 02/23/2018 and 02/23/2019 and expire on 02/23/2026. Sales occurred between $41.00 and $41.57 per share.
CNO Financial Group filed a Form 13F Holdings Report disclosing institutional holdings with a reported aggregate market value of $150,574,388 across 14 holdings. The filing lists one other included manager, 40|86 Advisors, Inc., and was signed on 11-13-2025.
CNO: A holder filed a Form 144 notice to sell up to 48,665 shares of common stock, with an aggregate market value $2,007,012.73. The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services as broker, an approximate sale date of 11/10/2025, and the NYSE as the exchange.
The shares were acquired via a stock option exercise on 11/10/2025 with cash payment. Shares outstanding were 95,353,512, providing baseline context.
CNO Financial Group reported Q3 2025 net income of $23.1 million, or $0.24 per diluted share, up from $9.3 million a year earlier, as revenues grew to $1,188.7 million from $1,129.6 million.
For the first nine months of 2025, net income fell to $136.4 million from $237.9 million, largely due to a $96.7 million non-cash impairment that fully wrote off goodwill of $69.5 million and $27.2 million of other intangibles tied to the Optavise benefits business.
At September 30, 2025, total assets were $38,296.2 million, with investments of $29,177.1 million and shareholders’ equity of $2,611.0 million. Operating cash flow for the nine-month period was $480.0 million, while the company returned capital via $259.9 million of share repurchases and $50.0 million in common dividends.